Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001013762-23-003902

President, CEO & Director gave up 87,531 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MARTELL RON President, CEO & Director 2023-10-12 Shares withheld for taxes −87,531 $0.85 $74,401 331,188 D: show line 1 in the form
Loading xslF345X05/ownership.xml…